Switchable wound treatment

Switchable wound treatment at Month 47. This deliverable is the responsibility of UC3M. Here we will test the response of wounds to remote activation in vivo. If this works, one can imagine a product worn by people at high risk of injury, e.g., fire fighters, and if they get injured, then the treatment can be remotely activated.